Trials / Unknown
UnknownNCT05114902
PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study
Assessing the Impact of PCV13 on Pneumococcal Nasopharyngeal Colonization in Children 8 Weeks to ≤60 Months of Age Hospitalized for Pneumonia in the Philippines
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 451 (actual)
- Sponsor
- Asian Foundation for Tropical Medicine Inc. · Academic / Other
- Sex
- All
- Age
- 8 Weeks – 60 Months
- Healthy volunteers
- Not accepted
Summary
Prospective, observational, hospital based, nasopharyngeal carriage (NPC), vaccine effectiveness study Comparisons will be made in Filipino children, aged 8 weeks to ≤60 months of age at enrollment, who have been hospitalized with a radiologically-confirmed, community-acquired pneumonia (CAP).
Detailed description
This study will be the first of two phases (A and B). Phase A will compare a PCV13-vaccinated setting (SPMC) with an unvaccinated setting (PCMC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Nasopharyngeal swab | A sample obtained from the nasopharynx for detection of live pneumococci and pneumococcal respiratory carriage |
Timeline
- Start date
- 2021-11-24
- Primary completion
- 2023-07-31
- Completion
- 2024-11-01
- First posted
- 2021-11-10
- Last updated
- 2023-09-13
Locations
1 site across 1 country: Philippines
Source: ClinicalTrials.gov record NCT05114902. Inclusion in this directory is not an endorsement.